OLSALAZINE VERSUS PLACEBO IN THE TREATMENT OF MILD TO MODERATE ULCERATIVE-COLITIS - A RANDOMIZED DOUBLE-BLIND TRIAL

被引：50
作者：
FEURLE, GE
THEUER, D
VELASCO, S
BARRY, BA
WORDEHOFF, D
SOMMER, A
JANTSCHEK, G
KRUIS, W
机构：
[1] FRANKFURT HOCHST, PRAXIS DILLINGEN, HEILBRONN, GERMANY
[2] UNIV COLOGNE, MED KLIN, D-5000 COLOGNE 41, GERMANY
[3] ST MICHAEL KRANKENHAUS, VOLKLINGEN, GERMANY
[4] UNIV LUBECK, MED KLIN, LUBECK, GERMANY
来源：
GUT | 1989年 / 30卷 / 10期
关键词：
D O I：
10.1136/gut.30.10.1354
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1354 / 1361
页数：8
相关论文
共 38 条
[1]  
AZADKHAN AK, 1977, LANCET, V2, P892
[2]  
BARON JH, 1962, LANCET, V1, P1094
[3]  
BARTALSKY A, 1982, LANCET, V1, P960
[4]   INDUCTION OF AND ADAPTATION TO OLSALAZINE INDUCED INTESTINAL VOLUME LOAD [J].
BERGLINDH, T ;
LANDSTROM, E ;
BERGQVIST, E .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1988, 23 :24-28
[5]   SOLUBLE FUNCTIONAL POLYMERS .3. A POLYMERIC DRUG FOR TREATMENT OF INFLAMMATORY BOWEL-DISEASE [J].
BROWN, JP ;
MCGARRAUGH, GV ;
PARKINSON, TM ;
WINGARD, RE ;
ONDERDONK, AB .
JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (09) :1300-1307
[6]  
CELLO JP, 1983, GASTROINTESTINAL DIS, P1112
[7]  
CHAN RP, 1983, DIGEST DIS SCI, V18, P107
[8]   CLINICAL PHARMACOKINETICS OF SULFASALAZINE [J].
DAS, KM ;
DUBIN, R .
CLINICAL PHARMACOKINETICS, 1976, 1 (06) :406-425
[9]   ADVERSE REACTIONS DURING SALICYLAZOSULFAPYRIDINE THERAPY AND RELATION WITH DRUG-METABOLISM AND ACETYLATOR PHENOTYPE [J].
DAS, KM ;
EASTWOOD, MA ;
MCMANUS, JPA ;
SIRCUS, W .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (10) :491-495
[10]   AN ORAL PREPARATION TO RELEASE DRUGS IN THE HUMAN-COLON [J].
DEW, MJ ;
HUGHES, PJ ;
LEE, MG ;
EVANS, BK ;
RHODES, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :405-408
1234